American Society of Echocardiography (ASE)

The American Society of Echocardiography (ASE) is the key cardiovascular ultrasound medical society. ASE works to advance cardiac ultrasound, offers clinical education, research, government policy advocacy, and services to the professionals and the public.

Vector flow and blood speckle echocardiography imaging may unveil new clinical insights
Luc Mertens, MD, Hospital for Sick Children, Toronto, explains research and potential uses for ultrafast echo imaging.
Key things to remember when creating a cardio-oncology program
Marielle Scherrer-Crosbie, MD, explains what is needed to create a cardio-oncology program, and the role played by cardiac imagers.
Interest in strain echo imaging is rising, but hurdles remain
Marielle Scherrer-Crosbie, MD, told Cardiovascular Business that the current lack of reimbursement for strain echocardiography has been a challenge for care teams.
American Society of Echocardiography shares updated expert recommendations on pediatric, neonatal echo
These new guidelines provide a fresh look at topics ASE has not addressed with official society recommendations in many years.
AI models for cardiac amyloidosis could make a world of difference
Jeremy Slivnick, MD, spoke with Cardiovascular Business about AI's potential to transform how cardiac amyloidosis is diagnosed and treated.

New registry aims to improve quality of cardiovascular imaging

The American Society of Echocardiography (ASE) announced Jan. 29 its ImageGuideEcho registry is open to U.S. physicians. ImageGuideEcho is the first registry exclusively devoted to measuring quality in cardiovascular ultrasounds.

January 29, 2018

Paravalvular regurgitation rates slashed with SAPIEN 3 heart valves

The mortality risk associated with moderate to severe PVR was consistent with previous studies, wrote lead author Philippe Pibarot, DVM, PhD, and colleagues, but the rate of moderate or worse PVR dropped threefold when compared to previous SAPIEN valves.

November 27, 2017

Individual feedback key to reducing excessive ECGs

An educational intervention designed to reduce ordering of transthoracic echocardiograms (TTEs) informs physicians about their own test-ordering patterns and how their performance compares to their peers, according to recent research. Such knowledge can reduce inappropriate use of the tests.

August 30, 2017

Hitachi Healthcare Americas to Introduce the “Lisendo 880” at ASE 2017, the New Premium 2D and 3D Cardiovascular Ultrasound System by Hitachi

Premium cardiac and vascular imaging rises to a new standard as Hitachi Healthcare Americas introduces the new premium 2D and 3D cardiovascular ultrasound system, the LISENDO 880, at the American Society of Echocardiography 2017 in Baltimore, Maryland on June 3rd, 2017.

June 8, 2017

Toshiba Medical’s Premium Cardiac Ultrasound Solution Helps Clinicians Improve Diagnostic Accuracy

When advanced cardiac ultrasound imaging is needed for fast and confident diagnoses, Toshiba Medical, a Canon Group company, will showcase its AplioTM i900 at this year’s American Society of Echocardiography (ASE) 2017 annual meeting in Baltimore, Md., June 2–6, 2017 (Booth #313). The Aplio i900 system is the latest addition to the premium Aplio i-series ultrasound platform, providing cardiologists and cardiovascular sonographers an ultrasound solution with excellent imaging clarity and definition.

June 2, 2017

Digisonics Showcases New Enhancements for Streamlined Cardiovascular Workflows at ASE 2017

HOUSTON (May 30, 2017) – Digisonics (Booth #421) will exhibit its latest functionality for Cardiovascular Information Systems (CVIS) at the American Society of Echocardiography 28th Annual Scientific Sessions in Baltimore, Md.

May 30, 2017

Geoffrey A. Rose, MD, President, Sanger Heart & Vascular Institute

Pathways for Quality Care: Echocardiographers Ponder a Playbook for Imaging in Myocardial Infarction

Physicians in fields like cardiology have traditionally looked to clinical practice guidelines to help articulate the best evidence-based care for patients. The rapidly growing movement to value-based care is prompting clinicians—including echocardiographers—to carefully weigh a more focused and integrative approach to delivering consistent, quality medicine: care pathways.

April 21, 2017

$To prevent the risk of patients developing heart failure from chemotherapy agents in cancer care, patients are typically have their left ventricular ejection fraction (LVEF) or myocardial strain monitored using either echocardiography or equilibrium radionuclide angiography/multigated acquisition (ERNA/MUGA). If cardiac damager occurs, the treatment is discontinue or pause treatment. Cardiac imaging to assess chemotherapy-induced cardiotoxicity using strain echo.$

Succeeding with Cancer: Using Imaging to Avoid Treatment-induced Heart Failure

Treating today’s cancer patient no longer means simply targeting the cancer. Given the known cardiotoxicities of some established chemotherapies and the possibility that newer approaches may damage the heart, oncologists, cardiologists and imaging specialists now work together to detect and minimize the risk of treatment-induced heart failure.

March 22, 2017

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

American Society of Echocardiography (ASE)

Vector flow and blood speckle echocardiography imaging may unveil new clinical insights

Key things to remember when creating a cardio-oncology program

Interest in strain echo imaging is rising, but hurdles remain

American Society of Echocardiography shares updated expert recommendations on pediatric, neonatal echo

AI models for cardiac amyloidosis could make a world of difference

Around the web